Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324350 · ClinicalTrials.gov registry record · Phase 3
Intensive Glycemic Control and Skeletal Health Study
A Phase 3 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 3
- Development phase
- 7,287
- Enrollment target
NCT00324350: Completed Phase 3 study, sponsored by University of California, San Francisco.
NCT00324350 is a Phase 3 study that has completed, run by University of California, San Francisco. The registered enrollment target is 7,287 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (844% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00324350, a Phase 3 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 7,287 participants
- Enrollment target
Study Summary
The purpose of the ACCORD-BONE Study is to investigate the effects of intensive glycemic control for type 2 diabetes (in ACCORD participants) on factors related to bone health, including, fractures, falls, and bone mineral density.
Primary Outcome
The BONE ancillary study was initiated during recruitment for the main ACCORD trial. Beginning in January 2006, at the next annual visit participants were asked about the occurrence of any non-spine fractures since randomization. After the annual visit in 2006, participants were asked if they had suffered a fracture since their last annual visit. Reported fracture events were centrally adjudicated, based on radiology records, at the University of California, San Francisco (UCSF) with the adjudic
Interventions
- DRUG hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,287 participants |
| Start Date | 2003-10 |
| Est. Completion | 2009-06 |
| Phase | Phase 3 |
What the finished NCT00324350 record still lists
NCT00324350 is an interventional study that assigns participants to a tested intervention. Its 7,287 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (844% higher).
The record links to 0 conditions, and to 1 intervention - of which hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents is the first listed.
NCT00324350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00324350 about?
NCT00324350 is a clinical study titled "Intensive Glycemic Control and Skeletal Health Study". The purpose of the ACCORD-BONE Study is to investigate the effects of intensive glycemic control for type 2 diabetes (in ACCORD participants) on factors related to bone health, including, fractures, falls, and bone mineral density.
What is the current status of trial NCT00324350?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 7,287 participants. The study started on 2003-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00324350?
The interventions under investigation include: hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents (DRUG).
Who is sponsoring clinical trial NCT00324350?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00324350's enrollment target sits among peer trials
7,287 34th of 2000 higher than 1,967 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05049837 · 7,200 participants
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
- NCT06714929 · 7,200 participants · NA
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
- NCT02915198 · 7,410 participants · Phase 4
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia